Sodium dodecyl sulfate-capillary gel electrophoretic analysis of molecular mass microheterogeneity of β-trace protein in cerebrospinal fluid from patients with central nervous system diseases

Journal of Chromatography A

Volumn 802, Issue 1, 1998, Pages 143-148

  Hiraoka, Atsushi ^a   Arato, Teruyo ^b   Tominaga, Itaru ^c   Eguchi, Naomi ^d   Oda, Hiroshi ^e   Urade, Yoshihiro ^f  

^a KYORIN UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e Maruha Nichiro Holdings Inc   (Japan)

^f OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Trace proteins; Central nervous system diseases; Cerebrospinal fluid; Microheterogeneity; Proteins

Indexed keywords

PROTEIN;

ADULT; AGED; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CONFERENCE PAPER; FEMALE; GEL ELECTROPHORESIS; HUMAN; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL;

ADULT; AGED; BETA-GLOBULINS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID PROTEINS; COHORT STUDIES; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; SODIUM DODECYL SULFATE; SPINAL PUNCTURE;

EID: 0032478773     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(97)00909-6     Document Type: Conference Paper

References (22)

1. Clausen J. Proc. Soc. Exp. Biol. Med. 107:1961;170.
2. Watanabe K., Urade Y., Mäder M., Murphy C., Hayaishi O. Biochem. Biophys. Res. Commun. 203:1994;1110.
3. Urade Y., Tanaka T., Eguchi N., Kikuchi M., Kimura H., Toh T., Hayaishi O. J. Biol. Chem. 270:1995;1422.
4. Hoffmann A., Conradt H.S., Ross G.G., Nimtzu M., Lottspeich F., Wurster U. J. Neurochem. 61:1993;451.
5. Urade Y., Kitamura K., Ohishi H., Kaneko T., Mizuno N., Hayaishi O. Proc. Natl. Acad. Sci. USA. 90:1993;9070.
6. Blödorn B., Mäder M., Urade Y., Hayaishi O., Felgenhauer K., Bruck W. Neurosci. Lett. 209:1996;117.
7. Urade Y., Hayaishi O., Matsumura H., Watanabe K. J. Lipid Mediators Cell Signalling. 14:1996;71.
8. Hayaishi O. Prostaglandins. 51:1998;275.
9. Link H., Olsson J.E. Acta Neurol. Scand. 48:1972;57.
10. Felgenhauer K., Schadlish H.J., Nikic M. Kil. Wochenschr. 65:1987;764.
11. C. Lumsden, Multiple Sclerosis, Churchill Livingstone, London, 1972, p. 311.
12. Hiraoka A., Miura I., Hattori M., Tominaga I., Machida S. Biol. Pharm. Bull. 16:1993;949.
13. Hiraoka A., Arato T., Tominaga I., Anjyo A. J. Pharm. Biomed. Anal. 15:1997;1257.
14. F. Wiederkerhr, Advances in Electrophoresis, VCH, Weinheim, 1992, p. 241.
15. Urade Y., Fujimoto N., Kaneko T., Konishi A., Mizuno N., Hayaishi O. J. Biol. Chem. 262:1987;15132.
16. Yao X.Y., Regnier F.E. J. Chromatogr. 632:1993;191.
17. Cohen A.S., Karger B.L. J. Chromatogr. 397:1987;413.
18. Ganzler K., Greve K.S., Cohen A.S., Karger B.L., Guttman A., Cooke N.C. Anal. Chem. 64:1992;2669.
19. Tsuji K. J. Chromatogr. 550:1991;823.
20. A. Hiraoka, T. Arato, I. Tomimaga, N. Eguchi, H. Oda, Y. Urade, J. Chromatogr. B (in press).
21. Oda H., Eguchi N., Urade Y., Hayaishi O. Proc. Japan Acad. 72:1996;108.
22. Hochwald G.M., Thorbeche G.J. Proc. Soc. Exp. Biol. Med. 109:1962;91.